FDA's anti-industry shift under Marty Macri
The guest argued that the FDA under Commissioner Marty Macri has shifted from a pro-industry, solutions-oriented approach to one that is dogmatic, anti-biologic, and influenced by political movements, leading to a sharp decline in biologic drug approvals.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.